Ignite Creation Date:
2025-12-25 @ 2:51 AM
Ignite Modification Date:
2026-06-28 @ 9:38 AM
Study NCT ID:
NCT05091333
Status:
COMPLETED
Last Update Posted:
2025-05-14
First Post:
2021-09-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
FASENRA Regulatory Postmarketing Surveillance in Korea
Sponsor:
AstraZeneca
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Asthma, EGPA(Eosinophilic Granulomatosis With Polyangiitis) | View |
Keywords: